FDA Compounding Pharmacy Crackdown Includes Citations For Ribavirin, Propulsid
This article was originally published in The Pink Sheet Daily
Executive Summary
The citations are part of warning letters issued for compounding of domperidone, a lactation product which is not approved by FDA. The agency issues a Talk Paper that warns breastfeeding women about the safety risks of domperidone.